CompletedNot Applicable

Evaluating HITSystem 2.1 to Improve Viral Suppression in Kenya

Kenya1,639 participantsStarted 2020-10-05

Plain-language summary

The goal of this project is to rigorously evaluate the efficacy of HIV Infant Tracking System 2.1 (HITSystem, an eHealth intervention that uses short message service (SMS) texts to patients and algorithm-driven electronic alerts for providers) to increase retention in guideline-adherent prevention of mother-to-child transmission of HIV services (PMTCT) and to increase viral suppression and appropriate clinical action through the extended period of 6 months postpartum, compared to standard of care PMTCT services in a matched, cluster randomized controlled trial.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women living with HIV who present for care at one of the study hospitals by 36 weeks gestation and provide written informed consent are eligible for enrollment in the study. Exclusion Criteria: * Pregnant women living with HIV will be excluded from study participation if she has any condition (including drug abuse, alcohol abuse, or psychiatric disorder) that study or hospital staff feel precludes her from providing informed consent. * Women who transfer care from one study site to another during their PMTCT services will be ineligible for enrollment at their new facility.

What they're measuring

Number of Participants Receiving Complete PMTCT

Timeframe: 7-15 months (PMTCT enrollment date through 6 months postpartum)

Viral Suppression

Timeframe: 1-9 months

Trial details

NCT IDNCT04571684

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-01

Results submitted2025-05-09

View on ClinicalTrials.gov More HIV trials